Use of prebiotics, preferably glucooligosaccharide, for the prevention of the onset of type ii diabetes

摘要

The use of probiotics (A) is claimed in the production of food or pharmaceutical compositions for preventing the onset of type II diabetes mellitus patients in patients having a predisposition towards this condition. Independent claims are included for: (a) (I)-containing food, food additive, 'alicament' or nutraceutical compositions for feeding obese (or potentially obese) subjects having a predisposition towards diabetes, to prevent the onset of type II diabetes; and (b) pharmaceutical compositions (not restricted to use as above) comprising one or more (I) and a pharmaceutical carrier.